Trial
NCT03608163
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Albert Einstein College of Medicine
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Diabetes Mellitus, Type 1
Intervention
Naloxone
Why stopped
Study suspended for a prolonged duration due to the Pandemic. Once research resumed project was streamlined due to insufficient resources. Study was sufficiently powered to conduct analysis for 2 of the arms. Remaining Aims were never initiated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-11